☆ 4.7 Letter

Reanalysis of TransVax immunogenicity

LANCET INFECTIOUS DISEASES (2013)

期刊

LANCET INFECTIOUS DISEASES

卷 13, 期 1, 页码 18-18

出版社

ELSEVIER SCIENCE INC

DOI: 10.1016/S1473-3099(12)70296-7

关键词

-

类别

Infectious Diseases

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Geochemistry & Geophysics

Reanalysis in Earth System Science: Toward Terrestrial Ecosystem Reanalysis

R. Baatz, H. J. Hendricks Franssen, E. Euskirchen, D. Sihi, M. Dietze, S. Ciavatta, K. Fennel, H. Beck, G. De Lannoy, V. R. N. Pauwels, A. Raiho, C. Montzka, M. Williams, U. Mishra, C. Poppe, S. Zacharias, A. Lausch, L. Samaniego, K. Van Looy, H. Bogena, M. Adamescu, M. Mirtl, A. Fox, K. Goergen, B. S. Naz, Y. Zeng, H. Vereecken

Summary: Reanalysis involves merging simulated model states and observational data through data assimilation. Recent developments have led to Earth system specific reanalysis products for the atmosphere, ocean, and land, with advanced uncertainty quantification and biogeochemical reanalysis included.

REVIEWS OF GEOPHYSICS (2021)

添加到收藏夹

Article Computer Science, Artificial Intelligence

Enhanced spatio-temporal electric load forecasts using less data with active deep learning

Arsam Aryandoust, Anthony Patt, Stefan Pfenningert

Summary: To enable electrification of cities and achieve accurate predictions of electricity consumption, an active deep learning approach is developed to forecast electric load profiles at the scale of single buildings. By leveraging additional computation and remotely sensed data, active learning enables more accurate predictions with less data compared to passive learning.

NATURE MACHINE INTELLIGENCE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Storage power purchase agreements to enable the deployment of energy storage in Europe

Paolo Gabrielli, Philipp Hilsheimer, Giovanni Sansavini

Summary: This article proposes a contractual setup called proxy storage power purchase agreement (PPA) to promote the deployment of energy storage technologies. By calculating the threshold price, the study finds that the PPA is financially attractive for PPA buyers and predicts the threshold prices for storage technologies and configurations in the European region for the next ten years. The research also identifies the UK and Germany as the most attractive countries for storage PPAs, and suggests coupling storage with wind energy generation to maximize revenues.

ISCIENCE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Evaluation of spatial-temporal variation performance of ERA5 precipitation data in China

Donglai Jiao, Nannan Xu, Fan Yang, Ke Xu

Summary: ERA5 is the latest fifth-generation reanalysis global atmosphere dataset from the European Centre for Medium-Range Weather Forecasts, replacing ERA-Interim as the next generation of representative satellite-observational data on the global scale. ERA5 data have been evaluated and applied in different regions, but the performances are inconsistent. This study evaluates the temporal-spatial performance of ERA5 precipitation data from 1979 to 2018 based on gridded-ground meteorological station observational data across China, showing that ERA5 captures the patterns of observed precipitation well but slightly overestimates precipitation in the summer, with accuracy varying across different regions in China.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19

Chih-Jung Chen, Lan-Yan Yang, Wei-Yang Chang, Yhu-Chering Huang, Cheng-Hsun Chiu, Shin-Ru Shih, Chung-Guei Huang, Kuan-Ying A. Huang

Summary: Heterologous prime-boost COVID-19 vaccine strategy can enhance mass immunization. This study demonstrates the early immunogenicity and safety outcomes of heterologous immunization with a viral vector vaccine and a spike-2P subunit vaccine. The results show superior neutralizing antibody titers and enhanced immune cell responses in the heterologous group, supporting the use of this strategy for COVID-19 immunization.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Economics

Centralized and decentral approaches to succeed the 100% energiewende in Germany in the European context - A model-based analysis of generation, network, and storage investments

Mario Kendziorski, Leonard Goeke, Christian von Hirschhausen, Claudia Kemfert, Elmar Zozmann

Summary: In this paper, the centralized and decentralized approaches to succeed the energiewende in Germany were explored. The results showed that although the cost of the two approaches were similar, the centralized approach requires network expansion, while the decentralized approach focuses more on local capacities.

ENERGY POLICY (2022)

添加到收藏夹

Article Biochemical Research Methods

Humanization of antibodies using a machine learning approach on large-scale repertoire data

Claire Marks, Alissa M. Hummer, Mark Chin, Charlotte M. Deane

Summary: The study developed machine learning classifiers to distinguish between human and non-human antibody sequences, and used them to create a computational humanization tool, Hu-mAb, which suggests mutations to reduce immunogenicity of antibody therapeutics. The tool's results show a negative relationship with experimental immunogenicity and can effectively replace trial-and-error humanization experiments in a shorter amount of time.

BIOINFORMATICS (2021)

添加到收藏夹

Article Medicine, General & Internal

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley, Cristina Ariani, Brian Angus, Sagida Bibi, Beth Blane, David Bonsall, Paola Cicconi, Sue Charlton, Elizabeth A. Clutterbuck, Andrea M. Collins, Tony Cox, Thomas C. Darton, Christina Dold, Alexander D. Douglas, Christopher J. A. Duncan, Katie J. Ewer, Amy L. Flaxman, Saul N. Faust, Daniela M. Ferreira, Shuo Feng, Adam Finn, Pedro M. Folegatti, Michelle Fuskova, Eva Galiza, Anna L. Goodman, Catherine M. Green, Christopher A. Green, Melanie Greenland, Bassam Hallis, Paul T. Heath, Jodie Hay, Helen C. Hill, Daniel Jenkin, Simon Kerridge, Rajeka Lazarus, Vincenzo Libri, Patrick J. Lillie, Catherine Ludden, Natalie G. Marchevsky, Angela M. Minassian, Alastair C. McGregor, Yama F. Mujadidi, Daniel J. Phillips, Emma Plested, Katrina M. Pollock, Hannah Robinson, Andrew Smith, Rinn Song, Matthew D. Snape, Rebecca K. Sutherland, Emma C. Thomson, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya L. Villafana, Christopher J. Williams, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Merryn Voysey, Maheshi N. Ramasamy, Andrew J. Pollard

Summary: A post-hoc analysis was conducted on the efficacy of the ChAdOx1 nCoV-19 vaccine against the B.1.1.7 variant of SARS-CoV-2 in the UK. The vaccine showed reduced neutralisation activity against the B.1.1.7 variant in vitro, but still demonstrated efficacy against the B.1.1.7 variant of the virus.

LANCET (2021)

添加到收藏夹

Article Biochemical Research Methods

Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays

Kevin R. Bewley, Naomi S. Coombes, Luc Gagnon, Lorna McInroy, Natalie Baker, Imam Shaik, Julien R. St-Jean, Natalie St-Amant, Karen R. Buttigieg, Holly E. Humphries, Kerry J. Godwin, Emily Brunt, Lauren Allen, Stephanie Leung, Phillip J. Brown, Elizabeth J. Penn, Kelly Thomas, Greg Kulnis, Bassam Hallis, Miles Carroll, Simon Funnell, Sue Charlton

Summary: The protocol from Public Health England discusses the use of three assays to measure neutralizing antibodies against SARS-CoV-2 for assessing COVID-19 vaccine efficacy. The PRNT is considered the gold standard for measuring levels of neutralizing antibodies, while the MNA and PNA offer advantages in terms of assay time, throughput, and operator workload. These assays have been critical in the development and licensure of COVID-19 vaccines and are important for demonstrating bioequivalence of future vaccines.

NATURE PROTOCOLS (2021)

添加到收藏夹

Article Geosciences, Multidisciplinary

TIM: modelling pathways to meet Ireland's long-term energy system challenges with the TIMES-Ireland Model (v1.0)

Olexandr Balyk, James Glynn, Vahid Aryanpur, Ankita Gaur, Jason McGuire, Andrew Smith, Xiufeng Yue, Hannah Daly

Summary: Ireland has significantly increased its climate mitigation ambition with commitments to reduce greenhouse gases by an average of 7% annually until 2030 and achieve net-zero emissions by 2050. To address energy challenges, they have developed an energy system optimization model called TIMES-Ireland Model (TIM), which takes into account Ireland's unique energy system context and uses various features and cross-model harmonization to meet their deep decarbonization goals.

GEOSCIENTIFIC MODEL DEVELOPMENT (2022)

添加到收藏夹

Article Meteorology & Atmospheric Sciences

A Global Climatology of Tropopause Folds in CAMS and MERRA-2 Reanalyses

Dimitris Akritidis, Andrea Pozzer, Johannes Flemming, Antje Inness, Prodromos Zanis

Summary: Tropopause folds play a critical role in stratosphere-to-troposphere transport and impact tropospheric composition and weather systems. The study presents the global climatology of tropopause folds from 2003 to 2018, showing that most folds are vertically shallow and located near subtropical jet streams, with deeper folds over storm tracks. Both CAMS and MERRA-2 reanalyses exhibit good spatiotemporal agreement in fold characteristics, particularly in the Northern Hemisphere.

JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses

Janice Zhirong Jia, Chee Wah Tan, Samuel M. S. Cheng, Haogao Gu, Aileen Ying Yan Yeoh, Chris Ka Pun Mok, Yanqun Wang, Jincun Zhao, Nancy H. L. Leung, Benjamin J. Cowling, Leo L. M. Poon, David S. C. Hui, Linfa Wang, Malik Peiris, Sophie A. Valkenburg

Summary: Vaccination and infection history play a crucial role in determining the breadth of neutralizing antibody response to SARS-CoV-2 variants and other sarbecoviruses. mRNA vaccines, particularly booster doses, provide the highest level of neutralization. Developing vaccines that can protect against a wide range of current and future SARS-CoV-2 variants and sarbecoviruses is a priority for public health.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Using historical tropical cyclone climate datasets to examine wind speed recurrence for coastal Australia

S. S. Bell, A. J. Dowdy, H. A. Ramsay, S. S. Chand, C-H Su, H. Ye

Summary: The study compares the estimates of extreme winds, specifically from tropical cyclones, using different datasets and analyzes the trends in TC wind strength affecting coastal Australia. The findings suggest that using climate model products can provide useful information on wind load standards, although there may be some limitations and uncertainties in the analysis. The study also highlights the potential regional changes in TC frequency and track direction, indicating the need for further research and longer-term evaluation using climate models.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma

S. C. Sasson, L. E. Wilkins, R. A. Watson, C. Jolly, O. Brain, P. Klenerman, A. Olsson-Brown, B. P. Fairfax

Summary: The development of anti-drug antibodies (ADAs) can interfere with therapeutic monoclonal antibodies, but their presence did not correlate with clinical progression at 6 months in patients receiving pembrolizumab for melanoma. Some patients showed a decline in pembrolizumab drug levels and an increase in ADA titers, suggestive of neutralizing ADAs. Larger studies are needed to determine the impact of neutralizing ADAs on long-term clinical outcomes.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Cas9-derived peptides presented by MHC Class II that elicit proliferation of CD4+ T-cells

Vijaya L. Simhadri, Louis Hopkins, Joseph R. McGill, Brian R. Duke, Swati Mukherjee, Kate Zhang, Zuben E. Sauna

Summary: The study found that some individuals have immune responses against Cas9, potentially affecting the application of gene therapy, and identified specific peptide segments that stimulate immune cells, providing reliable data support for further research.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma

J. Doukas, A. Rolland

CANCER GENE THERAPY (2012)

添加到收藏夹

Article Pharmacology & Pharmacy

Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines

Sean M. Sullivan, John Doukas, Jukka Hartikka, Larry Smith, Alain Rolland

EXPERT OPINION ON DRUG DELIVERY (2010)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults

Wendy A. Keitel, John J. Treanor, Hana M. El Sahly, Thomas G. Evans, Scott Kopper, Vanessa Whitlow, Cheryl Selinsky, David C. Kaslow, Alain Rolland, Larry R. Smith, Peggy A. Lalor

HUMAN VACCINES (2009)

添加到收藏夹

Article Chemistry, Multidisciplinary

Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors

Nicholas A. Peppas, Ruth Duncan, Gary E. Wnek, Allan S. Hoffman, Guang Hui Gao, SungWan Kim, Doo Sung Lee, Michael Hadjiargyrou, Elka Touitou, Denize Ainbinde, Russell Mumper, Alain Rolland, Takuro Niidome, Vinod Labhasetwar, Shi Liu, Guangyuan Zhou, Yubin Huang, Zhigang Xie, Xiabin Jing, Noemi Csaba, Maria Jose Alonso, Omar Ali, David J. Mooney, Peter Loenn, Steven F. Dowdy, Si-Shen Feng, Jinming Gao, Eun Seong Lee, Kun Na, You Han Bae, Gaylen M. Zentner, Hye Sung Kim, Hyuk Sang Yoo, Masamichi Nakayama, Teruo Okano, Zi-Xian Liao, Er-Yuan Chuang, Chun-Wen Hsiao, Hsing-Wen Sung, Horacio Cabral, Kazunori Kataoka, Praful R. Nair, Discher Discher, Samir Mitragotri

JOURNAL OF CONTROLLED RELEASE (2014)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection

Mark Shlapobersky, Joshua O. Marshak, Lichun Dong, Meei-Ii Huang, Qun Wei, Alice Chu, Alain Rolland, Sean Sullivan, David M. Koelle

JOURNAL OF GENERAL VIROLOGY (2012)

添加到收藏夹

Article Immunology

Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus

Peggy A. Lalor, Richard J. Webby, Jane Morrow, Denis Rusalov, David C. Kaslow, Alain Rolland, Larry R. Smith

JOURNAL OF INFECTIOUS DISEASES (2008)

添加到收藏夹

Article Virology

Vaxfectin Adjuvant Improves Antibody Responses of Juvenile Rhesus Macaques to a DNA Vaccine Encoding the Measles Virus Hemagglutinin and Fusion Proteins

Wen-Hsuan W. Lin, Adrian Vilalta, Robert J. Adams, Alain Rolland, Sean M. Sullivan, Diane E. Griffin

JOURNAL OF VIROLOGY (2013)

添加到收藏夹

Article Infectious Diseases

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

Mohamed A. Kharfan-Dabaja, Michael Boeckh, Marissa B. Wilck, Amelia A. Langston, Alice H. Chu, Mary K. Wloch, Don F. Guterwill, Larry R. Smith, Alain P. Rolland, Richard T. Kenney

LANCET INFECTIOUS DISEASES (2012)

添加到收藏夹

Article Immunology

Vaxfectin (R), a cationic lipid-based adjuvant for protein-based influenza vaccines

Jukka Hartikka, Vesselina Bozoukova, Catherine K. Yang, Ming Ye, Denis Rusalov, Mark Shlapobersky, Adrian Vilalta, Qun Wei, Alain Rolland, Larry R. Smith

VACCINE (2009)

添加到收藏夹

Article Immunology

Analysis of biomarkers after intramuscular injection of Vaxfectin®-formulated hCMV gB plasmid DNA

Adrian Vilalta, Mark Shlapobersky, Qun Wei, Rodrick Planchon, Alain Rolland, Sean Sullivan

VACCINE (2009)

添加到收藏夹

Article Immunology

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

Larry R. Smith, Mary K. Wloch, Ming Ye, Luane R. Reyes, Souphaphone Boutsaboualoy, Casey E. Dunne, Jennifer A. Chaplin, Denis Rusalov, Alain P. Rolland, Cindy L. Fisher, Mohamed S. Al-Ibrahim, Martin L. Kabongo, Roy Steigbigel, Robert B. Belshe, Ernest R. Kitt, Alice H. Chu, Ronald B. Moss

VACCINE (2010)

添加到收藏夹

Article Immunology

Nonclinical biodistribution, integration, and toxicology evaluations of an H5N1 pandemic influenza plasmid DNA vaccine formulated with Vaxfectin®

John Doukas, Jane Morrow, Dawn Bellinger, Thomas Hilgert, Terrie Martin, Doug Jones, Rohit Mahajan, Denis Rusalov, Sean Sullivan, Alain Rolland

VACCINE (2011)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus

Jukka Hartikka, Vesselina Bozoukova, Jane Morrow, Denis Rusalov, Mark Shlapobersky, Qun Wei, Sou Boutsaboualoy, Ming Ye, Mary K. Wloch, John Doukas, Sean Sullivan, Alain Rolland, Larry R. Smith

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Preclinical evaluation of Vaxfectin (R)-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines

Larry R. Smith, Walter Wodal, Brian A. Crowe, Astrid Kerschbaum, Peter Bruehl, Michael G. Schwendinger, Helga Savidis-Dacho, Sean M. Sullivan, Mark Shlapobersky, Jukka Hartikka, Alain Rolland, P. Noel Barrett, Otfried Kistner

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.